[HTML][HTML] Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease in mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - PloS one, 2016 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease.
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - 2016 - cabidigitallibrary.org
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
[PDF][PDF] Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - PLoS ONE, 2016 - academia.edu
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba… - PLoS …, 2016 - search.ebscohost.com
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
[HTML][HTML] Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
[引用][C] Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - PLOS ONE, 2016 - cir.nii.ac.jp
Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat
Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice | CiNii Research CiNii 国立情報学 …
Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice | CiNii Research CiNii 国立情報学 …
[PDF][PDF] Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba… - PLoS ONE, 2016 - scienceopen.com
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease in mice
SK Noriko, T Matsuzaka, M Kuba, H Ohno… - PLoS …, 2016 - u-toyama.elsevierpure.com
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
Different effects of eicosapentaenoic and docosahexaenoic acids on atherogenic high-fat diet-induced non-alcoholic fatty liver disease in mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba, H Ohno… - PLoS ONE, 2016 - go.gale.com
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
[PDF][PDF] Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
N Suzuki-Kemuriyama, T Matsuzaka, M Kuba… - PLoS …, 2016 - pdfs.semanticscholar.org
Non-alcoholic fatty liver disease (NAFLD), the hepatic manifestation of metabolic syndrome,
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …
can progress to steatohepatitis (NASH) and advanced liver damage, such as that from liver …